Literature DB >> 15293078

Management of infection associated with total hip arthroplasty according to a treatment algorithm.

S G Giulieri1, P Graber, P E Ochsner, W Zimmerli.   

Abstract

BACKGROUND: An algorithm for the management of hip arthroplasty-associated infections was validated in a cohort study. PATIENTS: 60 patients with 63 episodes of total hip arthroplasty-associated infections observed from 1985 to 2001 were included. The treatment algorithm was based on the time of manifestation, pathogenesis, and condition of implant and soft tissue. Three treatment options were proposed, namely debridement with retention, one-stage and two-stage replacement.
RESULTS: The median patients' age was 72 years, the median follow-up 28 months; 29% were early, 41% delayed, and 30% late infections, 57% of the infections were exogenously and 43% hematogenously acquired. The overall success rate for the first treatment attempt was 83% (52/63). Patients treated according to the algorithm had a better outcome than the others (44/50 = 88% vs 8/13 = 62%, Relative risk (RR) 0.31, 95% confidence interval (CI): 0.11-0.86, p < 0.03); those treated with adequate antimicrobial therapy had a better success rate (87% vs. 50%, p < 0.01).
CONCLUSION: The proposed algorithm defines a rational surgical/antibiotic treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293078     DOI: 10.1007/s15010-004-4020-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  62 in total

1.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.

Authors:  O C El Helou; E F Berbari; B D Lahr; J E Eckel-Passow; R R Razonable; I G Sia; A Virk; R C Walker; J M Steckelberg; W R Wilson; A D Hanssen; D R Osmon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-27       Impact factor: 3.267

2.  Is two-stage reimplantation effective for virulent pathogenic infection in a periprosthetic hip? A retrospective analysis.

Authors:  Yong-Cheol Yoon; Devendra Lakhotia; Jong-Keon Oh; Jun Gyu Moon; Kumar Prashant; Won Yong Shon
Journal:  World J Orthop       Date:  2015-10-18

3.  Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers.

Authors:  Rashid Tikhilov; Svetlana Bozhkova; Alexey Denisov; Dmitry Labutin; Igor Shubnyakov; Vadim Razorenov; Vasilii Artyukh; Olga Klitsenko
Journal:  Int Orthop       Date:  2015-12-19       Impact factor: 3.075

4.  Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?

Authors:  Trisha N Peel; Allen C Cheng; Kirsty L Buising; Peter F M Choong
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

5.  [Histopathologic diagnosis of infectious loosening of joint prostheses].

Authors:  I Bos; M Zagorski; C Boos; S Krüger
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

6.  [Diagnostics and therapy of luxation after total hip arthroplasty].

Authors:  B Preininger; F Haschke; C Perka
Journal:  Orthopade       Date:  2014-01       Impact factor: 1.087

7.  High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Raluca Mihailescu; Ulrika Furustrand Tafin; Stéphane Corvec; Alessandra Oliva; Bertrand Betrisey; Oliver Borens; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Six weeks antibiotic therapy for all bone infections: results of a cohort study.

Authors:  R Farhad; P-M Roger; C Albert; C Pélligri; C Touati; P Dellamonica; C Trojani; P Boileau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-10       Impact factor: 3.267

Review 9.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  Joint prosthetic infections: a success story or a continuous concern?

Authors:  Geert H I M Walenkamp
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.